AVDL vs PAHC โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
PAHC Captures Institutional Edge (3โ1 Pillars ยท 6โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Phibro Animal Health Corporation Class A (PAHC) driven by superior Valuation, Growth & Margin, Options & Structure while AVDL counters with relative strength in Momentum & Technical. Fundamentally, AVDL trades at 28.8x Forward P/E with 2.5% operating margin (+54.9% YoY revenue) versus PAHC at 10.0x Forward P/E and 12.7% operating margin (+6.3% YoY). In options structure, AVDL sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro) against PAHC sits in CONSOLIDATION (9th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | AVDL | PAHC | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $2.1B | $1.4B | Larger Scale | AVDL |
| Trailing P/E Ratio Valuation | 16.8x | 14.2x | Lower Multiple | PAHC |
| Forward P/E Ratio Valuation | 28.8x | 10.0x | Lower Multiple | PAHC |
| Revenue Growth (YoY) Growth | +54.9% | +6.3% | Higher Growth | AVDL |
| Operating Margin (TTM) Profitability | 2.5% | 12.7% | Higher Margin | PAHC |
| Net Profit Margin Profitability | -0.1% | 6.7% | Higher Margin | PAHC |
| Return on Equity (ROE) Capital Efficiency | -0.3% | 28.2% | Higher ROE | PAHC |
| 52-Week Range Position Momentum | 89% ($6โ$24) | 16% ($28โ$60) | Stronger Trend | AVDL |
| Beta / 30D Volatility Risk Regime | 0.14ฮฒ ยท 2% Vol | 1.04ฮฒ ยท 55% Vol | Lower Realized Risk | AVDL |
| Unified Institutional Score Composite Signal | 62.9 / 100 (BUY) | 65.9 / 100 (BUY) | Higher Composite | PAHC |